Showing 1 - 2 results of 2 for search 'David Neveu', query time: 0.02s Refine Results
  1. 1
    Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older

    Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older by David Neveu, Tamala Mallett Moore, Betzana Zambrano, Aiying Chen, Marie-Laure Kürzinger, Lydie Marcelon, Mandeep Singh Dhingra

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

    Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 y... by Franco M. Piazza, Miia Virta, Marita Paassilta, Benita Ukkonen, Anitta Ahonen, Alejandra Esteves-Jaramillo, Aino Forsten, Ilkka Seppa, Jian Ding, David Neveu, Emilia Jordanov, Mandeep S. Dhingra

    Published 2022-01-01
    Get full text
    Article

Search Tools: